Skip subnavigation and go to article content

Berkeley infectious disease expert studies SARS-CoV-2 live virus in her UC Berkeley lab

Click or tap video thumbnail to play

Sarah Stanley, an infectious disease expert at UC Berkeley, normally researches tuberculosis in her lab. But when the COVID-19 pandemic shut down all normal research operations on campus, she quickly utilized her own discretionary funds to mobilize her lab and student researchers to study the SARS-CoV-2 live virus.

A partnership with Julia Schaletzky, Executive Director of Berkeley’s Center for Emerging and Neglected Diseases, has allowed Stanley’s lab to test whether pre-existing, FDA approved drugs would have any effect on killing the virus.

Video by Stephen McNally.